SAMHSA will award OD Treatment Access funds to Federally Qualified Health Centers (FQHC), Opioid Treatment Programs, or practitioners who have a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.

Funding Opportunity Title: Improving Access to Overdose Treatment
Funding Opportunity Number: SP-18-006
Due Date for Applications: June 4, 2018
Anticipated Total Available Funding: Up to $940,000
Estimated Number of Awards: Up to 5
Estimated Award Amount: Up to $200,000 per year
Link to Funding Opportunity Announcement Request for Proposals
Anticipated Project Start Date: September 30, 2018
Length of Project Period: Up to 5 years
Eligible Applicants: SAMHSA is limiting eligibility to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and   practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act.

[See Section III-1 for complete eligibility information.]